Skip to main content
logo
Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
39.80
-0.45 (-1.12%)
At close: Jul 2, 2026, 4:00 PM EDT
40.59
+0.79 (1.98%)
After-hours: Jul 2, 2026, 6:16 PM EDT

Indivior Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2522107-126-44213
Depreciation & Amortization
172028151622
Stock-Based Compensation
292624211611
Other Adjustments
3.5-262388-110-49
Change in Receivables
-283-1-33-21-25
Changes in Inventories
1218-43-6-30-3
Changes in Accounts Payable
-----201
Changes in Accrued Expenses
-344-368-38750197-
Changes in Income Taxes Payable
------17
Changes in Other Operating Activities
-7790385-308-280
Operating Cash Flow
-111-2736-300-4353
Capital Expenditures
-81-66-29-8-5-4
Purchases of Intangible Assets
-0.5-1-2-45--30
Proceeds from Sale of Intangible Assets
-----20
Purchases of Investments
-20-20-17-45-245-
Proceeds from Sale of Investments
192011712927-
Payments for Business Acquisitions
----129--
Other Investing Activities
---31-
Investing Cash Flow
-80-6669-95-222-14
Long-Term Debt Issued
489-332--250
Long-Term Debt Repaid
-346-17-240-12-3-244
Net Long-Term Debt Issued (Repaid)
143-1792-12-36
Issuance of Common Stock
123321
Repurchase of Common Stock
-126-11-173-33-90-101
Net Common Stock Issued (Repurchased)
-125-9-170-30-88-100
Other Financing Activities
-25-5-24-22-10-
Financing Cash Flow
-6-30-102-64-101-94
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-1-1-1-1-1
Net Cash Flow
-197-1243-459-327244
Free Cash Flow
-192-937-308-9349
FCF Margin
-14.87%-7.51%0.59%-28.18%-1.00%44.12%
Free Cash Flow Per Share
-7.46-3.630.26-11.24-0.3211.48
Levered Free Cash Flow
-79-11353-395103410
Unlevered Free Cash Flow
-119.68-12.2116.7-428.92109.05428.82
SEC Filings: 10-K · 10-Q